Search Ontology: 
        
        ChEBI
            prostaglandin F2alpha
- Term ID
 - CHEBI:15553
 - Synonyms
 - 
    
        
        
- (+)-Prostaglandin F2a
 - (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate
 - (5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid
 - 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
 - 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid
 - 9a,11a-PGF2
 - Amoglandin
 - Cyclosin
 - dinoprost
 - dinoprosta
 - dinoprostum
 - Enzaprost
 - Enzaprost F
 - l-PGF2-alpha
 - l-Prostaglandin F2-alpha
 - Panacelan
 - PGF2a
 - PGF2alpha
 - Prostaglandin F2a
 - Prostaglandin F2alpha
 - Prostin F 2 alpha
 - Protamodin
 - U 14583
 
 - Definition
 - A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor.
 - References
 - 
    
        
        
    
    
- CAS:551-11-1
 - Drug_Central:912
 - HMDB:HMDB0001139
 - KEGG:C00639
 - KEGG:D00081
 - LIPID_MAPS_instance:LMFA03010002
 - MetaCyc:5Z13E-15S-9-ALPHA11-ALPHA15-TRIHY
 - PMID:11438482
 - PMID:23807981
 - Reaxys:2225571
 - VSDB:1803
 - Wikipedia:Dinoprost
 
 - Ontology
 - ChEBI ( EBI )
 - Resources
 - CTD
 
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from prostaglandin F2alpha
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain prostaglandin F2alpha
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing prostaglandin F2alpha
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting prostaglandin F2alpha
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model